1. Home
  2. ARDX vs GBX Comparison

ARDX vs GBX Comparison

Compare ARDX & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.78

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Greenbrier Companies Inc. (The)

GBX

Greenbrier Companies Inc. (The)

HOLD

Current Price

$46.72

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
GBX
Founded
2007
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Railroads
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ARDX
GBX
Price
$5.78
$46.72
Analyst Decision
Strong Buy
Sell
Analyst Count
10
3
Target Price
$10.65
$50.67
AVG Volume (30 Days)
2.7M
323.2K
Earning Date
10-30-2025
01-08-2026
Dividend Yield
N/A
2.73%
EPS Growth
N/A
27.96
EPS
N/A
6.35
Revenue
$398,234,000.00
$3,240,200,000.00
Revenue This Year
$22.77
N/A
Revenue Next Year
$28.02
N/A
P/E Ratio
N/A
$7.39
Revenue Growth
58.12
N/A
52 Week Low
$3.21
$37.77
52 Week High
$6.78
$71.06

Technical Indicators

Market Signals
Indicator
ARDX
GBX
Relative Strength Index (RSI) 48.64 60.04
Support Level $5.63 $46.02
Resistance Level $6.04 $46.78
Average True Range (ATR) 0.24 0.99
MACD -0.02 -0.08
Stochastic Oscillator 17.31 48.73

Price Performance

Historical Comparison
ARDX
GBX

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.

Share on Social Networks: